News
Investors
Contact
Home
About
Overview
Management Team
Board of Directors
Quality Management System
Sustainability
Technologies
Overview
Ethanol Fractionation Processes
Pressurized Gas Expanded (PGX) Technology
Chromatography Purification
Intellectual Property
Scientific Publications
Pipeline
Overview
Oat Beta Glucan
Avenanthramides
Product Brochures
Cosmeceuticals
Overview
Nutraceuticals
Overview
Oat Beta Glucan
Avenanthramides
Business Development
Overview
Partners
News
Investors
Contact
Home
News
Media Coverage
Media Coverage
Ceapro transitioning to biopharmaceutical company from contract manufacturer
May 7, 2019
Ceapro using patented technology to disrupt the natural health care products sector
May 2, 2019
Ceapro to begin clinical trials for beta glucan to treat high cholesterol
April 15, 2019
CEO Interview
January 22, 2019
Ceapro has big plans for oats
October 6, 2016
Alberta's Ceapro a diversification success story
September 28, 2016